Yali Liang

Yali Liang is an accomplished professional in the field of clinical pharmacology and pharmacometrics, currently serving as the Director of Global Clinical Pharmacology and Pharmacometrics at Jazz Pharmaceuticals since January 2022. Prior experience includes roles as Associate Director and Senior Research Investigator at Bristol Myers Squibb from 2018 to 2022, and Manager at Pfizer from 2010 to 2018, where responsibilities involved model-based analysis of clinical trial data and writing pharmacokinetic modeling reports for submission packages. Yali Liang's early career includes a position as Research Assistant at the University of Kentucky and an internship at Pfizer, as well as an Assistant Director role at the Centers for Disease Control and Prevention. Educational qualifications include a Master’s degree in Pharmacometrics from the University of Maryland, Baltimore, an MD from TongJi Medical College of HUST, a Master’s in Pharmaceutical Science from the University of Kentucky, and a Master of Public Health from TongJi Medical College of HUST.